Array Digital Infrastructure logo

Array Digital Infrastructure

AD | NYSE
Chart Builder DCF Calculator
$27.58
-$0.26 (-0.93%)
At close: Nov 16, 2026, 4:00 PM ET
$27.58
$0.00 (0.00%)
After-hours: Nov 16, 2026, 5:05 PM ET
-0.93%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
53.2
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #92/283 (Top 33%)

Key Statistics

Market Data

Market Cap $2.38B
1D Range
26.61 28.06
52W Range
26.61 60.28

Valuation (TTM)

PE 3.69
PB 1.79
EV/EBITDA 3.78

Valuation (NTM)

Forward PE 3.89
Forward PEG 0.00
Price Target $52.50
Loading financial charts...

Profile

Array Digital Infrastructure, Inc. owns and operates shared wireless communications infrastructure in the United States. The company deploys 5G and other wireless technologies through its 4,400 cell t...

Employees 60
IPO Date May 4, 1988
Fiscal Year January - December

Latest News

3 Wireless Stocks Likely to Benefit Despite Macroeconomic Challenges

20 days ago · zacks.com

3 Wireless Stocks Likely to Benefit Despite Macroeconomic Challenges
AD Q2 Earnings Beat Estimates on Strong Site Rental Growth

3 months ago · zacks.com

AD Q2 Earnings Beat Estimates on Strong Site Rental Growth
3 Wireless Stocks Set to Overcome Roadblocks on Industry Strength

4 months ago · zacks.com

3 Wireless Stocks Set to Overcome Roadblocks on Industry Strength
LAPIX Therapeutics Appoints Nimbus CEO Abbas Kazimi to Board of Directors

4 months ago · businesswire.com

LAPIX Therapeutics Appoints Nimbus CEO Abbas Kazimi to Board of Directors
AD Mortgage Survey Finds Growing Demand for Non-QM Lending Among Brokers

5 months ago · globenewswire.com

AD Mortgage Survey Finds Growing Demand for Non-QM Lending Among Brokers
Derm-Biome's DB-006 Demonstrates Superior Efficacy in Preclinical Atopic Dermatitis Study: Reduces Itch, Inflammation, and IgE Levels, Outperforms Leading Topical Drugs

5 months ago · globenewswire.com

Derm-Biome's DB-006 Demonstrates Superior Efficacy in Preclinical Atopic Dermatitis Study: Reduces Itch, Inflammation, and IgE Levels, Outperforms Leading Topical Drugs
Is It Too Late to Buy Array Digital Infrastructure Inc (AD) After 3.1% Rally? GF Value Says Undervalued

5 months ago · gurufocus.com

Is It Too Late to Buy Array Digital Infrastructure Inc (AD) After 3.1% Rally? GF Value Says Undervalued
Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer's Disease

6 months ago · gurufocus.com

Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer's Disease
AD Q1 Earnings Miss Estimates Despite Site Rental Growth

6 months ago · zacks.com

AD Q1 Earnings Miss Estimates Despite Site Rental Growth
3 Wireless Stocks Likely to Thrive Despite Short-Term Challenges

6 months ago · zacks.com

3 Wireless Stocks Likely to Thrive Despite Short-Term Challenges

Earnings

Latest Earnings
Nov 6, 2026
EPS
$0.81
Beat +147.63%
REV
$53.87M
Beat +0.36%
Next Earnings
Feb 19, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
5
Consensus
Buy
Price Target
$52.50
Upside
+90.36%
Buy (3)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.